Merck | MRK - Operating Expenses


Merck reported EUR4.34B in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Adidas EUR 6.17B 282M Jun/2026
Adyen EUR 889.68M 94.39M Jun/2026
Akzo Nobel EUR 2.34B 206M Jun/2026
Alcon AG USD 2.78B 370M Jun/2026
Amadeus IT EUR 1.17B 17.5M Jun/2026
Amarin USD 51.48M 113K Dec/2025
AstraZeneca USD 12.22B 4.04B Jun/2026
BASF EUR 15.77B 1.16B Jun/2026
Bayer EUR 10.04B 168M Jun/2026
Beiersdorf EUR 4.16B 212M Dec/2025
Covestro EUR 3.24B 5.46B Dec/2025
Danone EUR 12.08B 396M Jun/2026
Fresenius EUR 5.23B 9M Jun/2026
Fresenius Medical Care EUR 4.32B 20.7M Jun/2026
Genmab DKK 748M 77M Jun/2026
Givaudan CHF 3B 107M Dec/2025
GlaxoSmithKline GBP 5.8B 468M Jun/2026
GRIFOLS EUR 1.55B 94M Jun/2026
Henkel EUR 8.7B 35M Jun/2026
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Infineon EUR 3.57B 239M Jun/2026
Lakefront Biotherapeutics EUR 55.62M 14.56M Jun/2026
Linde USD 6.4B 112M Mar/2026
Lonza CHF 2.9B 184M Jun/2025
Merck EUR 4.34B 249M Jun/2026
Novartis USD 10.2B 912M Jun/2026
Philips EUR 3.75B 147M Jun/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
Sanofi EUR 9.92B 607M Jun/2026
UCB EUR 2.96B 196M Dec/2025